SCHEDULE 13D

Company

BIOREGENX, INC.

Filed

April 29, 2024

Accession Number

0001683168-24-002811

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →